Clinical trials
Recruiting beta-Thalassemia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bioray Laboratories | 2 |
| Celgene | 2 |
| Children's Hospital of Fudan University | 1 |
| First Affiliated Hospital of Guangxi Medical University | 1 |
| Guangzhou Women and Children's Medical Center | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Mabwell (Shanghai) Bioscience Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| beta-Thalassemia | 9 |
| Myelodysplastic Syndromes | 1 |
| Myeloproliferative Disorders | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.